Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
  • Pipeline
    • Overview
    • MT-5111
    • MT-0169
    • MT-6402
  • Clinical Trials
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Email Alerts
  • News & Events - HIDDEN

  • Overview
  • Press Releases
  • IR Calendar

Molecular Templates to Present at Upcoming Investor Conferences

May 17, 2022 4:05pm EDT

Molecular Templates, Inc. Reports First Quarter 2022 Financial Results

May 12, 2022 4:30pm EDT

Molecular Templates’ Presentations at the American Association of Cancer Research (AACR) Annual Meeting 2022 Highlight Potential of ETB Approach

Apr 12, 2022 7:30am EDT

Molecular Templates to Host Webinar on a Unique Approach to Immuno-Oncology for Solid Tumors

Apr 08, 2022 8:00am EDT

Molecular Templates, Inc. Reports Fourth Quarter 2021 Financial Results

Mar 28, 2022 4:30pm EDT

Molecular Templates Strengthens Board of Directors and Management Team

Mar 02, 2022 8:00am EST

Molecular Templates to Present at the Upcoming Investor Conferences

Mar 01, 2022 8:00am EST

Molecular Templates Provides Corporate Update and Outlines 2022 Milestones

Nov 30, 2021 5:30pm EST

Molecular Templates, Inc. Announces Fast Track Designation Granted by FDA for MT-6402

Nov 18, 2021 8:00am EST

Molecular Templates, Inc. Reports Third Quarter 2021 Financial Results

Nov 15, 2021 7:30am EST
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...11
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2022 Molecular Templates, Inc. All Rights Reserved.
Twitter Linkedin
Privacy Policy Disclaimer Terms of Use Sitemap Expanded Access